Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 161954, 5 pages
http://dx.doi.org/10.1155/2014/161954
Research Article

Preoperative Serum Levels of Mesothelin in Patients with Colon Cancer

1Şişli Hamidiye Etfal Training and Research Hospital General Surgery Clinic, Istanbul, Turkey
2Department of General Surgery, Yuzuncu Yil University Medical Faculty, Van, Turkey
3Department of Biochemistry, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey
4Department of Biostatistics, Istanbul University Medical Faculty, Istanbul, Turkey
5Department of Radiology, Yuzuncu Yil University Medical Faculty, Van, Turkey

Received 9 August 2014; Revised 26 October 2014; Accepted 27 October 2014; Published 13 November 2014

Academic Editor: Marco E. M. Peluso

Copyright © 2014 Özgür Bostancı et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer statistics, 2009,” CA Cancer Journal for Clinicians, vol. 59, no. 4, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Hofstad and M. Vatn, “Growth rate of colon polyps and cancer,” Gastrointestinal Endoscopy Clinics of North America, vol. 7, no. 3, pp. 345–363, 1997. View at Google Scholar · View at Scopus
  3. J. J. L. Wong, N. J. Hawkins, and R. L. Ward, “Colorectal cancer: a model for epigenetic tumorigenesis,” Gut, vol. 56, no. 1, pp. 140–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. F. K. Diallo Owono, R. Nguema Mve, J. Ibaba, C. Mihindou, and F. Ondo N'dong, “Epidemiological and diagnostic featurers of colorectal cancer in Libreville, Gabon,” Médecine Tropicale: Revue du Corps de Santé Colonial, vol. 71, no. 6, pp. 605–607, 2011. View at Google Scholar · View at Scopus
  5. O. G. Dominic, T. McGarrity, M. Dignan, and E. J. Lengerich, “American college of gastroenterology guidelines for colorectal cancer screening 2008,” The American Journal of Gastroenterology, vol. 104, no. 10, pp. 2626–2627, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Cristaudo, R. Foddis, A. Vivaldi et al., “Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer,” Clinical Cancer Research, vol. 13, no. 17, pp. 5076–5081, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. G. Moore, A. K. Brown, M. C. Miller et al., “Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus,” Gynecologic Oncology, vol. 110, no. 2, pp. 196–201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Fukuoka, K. Kuribayashi, S. Yamada et al., “Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma,” Molecular and clinical oncology, vol. 1, no. 6, pp. 942–948, 2013. View at Google Scholar
  9. N. P. Rizk, E. L. Servais, L. H. Tang et al., “Tissue and serum mesothelin are potential markers of neoplastic progression in Barrett's associated esophageal adenocarcinoma,” Cancer Epidemiology Biomarkers & Prevention, vol. 21, no. 3, pp. 482–486, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Tajima, M. Hirama, K. Shiomi et al., “ERC/Mesothelin as a marker for chemotherapeutic response in patients with mesothelioma,” Anticancer Research, vol. 28, no. 6, pp. 3933–3936, 2008. View at Google Scholar · View at Scopus
  11. N. T. van Heek, A. Maitra, J. Koopmann et al., “Gene expression profiling identifies markers of ampullary adenocarcinoma,” Cancer Biology and Therapy, vol. 3, no. 7, pp. 651–656, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Kawamata, S. Homma, H. Kamachi et al., “C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma,” Journal of Gastroenterology, vol. 49, no. 1, pp. 81–92, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Yamaguchi, K. Hattori, M. Oh-Eda, T. Kojima, N. Imai, and N. Ochi, “A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor cell line HPC-Y5,” The Journal of Biological Chemistry, vol. 269, no. 2, pp. 805–808, 1994. View at Google Scholar · View at Scopus
  14. T. Kojima, M. Oh-Eda, K. Hattori et al., “Molecular cloning and expression of megakaryocyte potentiating factor cDNA,” The Journal of Biological Chemistry, vol. 270, no. 37, pp. 21984–21990, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Chang and I. Pastan, “Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 1, pp. 136–140, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. E. Muminova, T. V. Strong, and D. R. Shaw, “Characterization of human mesothelin transcripts in ovarian and pancreatic cancer,” BMC Cancer, vol. 4, article 19, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Scholler, N. Fu, Y. Yang et al., “Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 20, pp. 11531–11536, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Hellstrom, J. Raycraft, S. Kanan et al., “Mesothelin variant 1 is released from tumor cells as a diagnostic marker,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 5, pp. 1014–1020, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Ho, M. Onda, Q.-C. Wang, R. Hassan, I. Pastan, and M. O. Lively, “Mesothelin is shed from tumor cells,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 9, p. 1751, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Creaney and B. W. S. Robinson, “Serum and pleural fluid biomarkers for mesothelioma,” Current Opinion in Pulmonary Medicine, vol. 15, no. 4, pp. 366–370, 2009. View at Publisher · View at Google Scholar · View at Scopus